Report Materials
The Indiana Hemophilia and Thrombosis Center, Inc. (the Center) received net Medicare overpayments for NovoSeven dispensations of $435,000 for the period January 1, 2008, through December 31, 2009.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.